Skip to main
PEPG
PEPG logo

PepGen Inc (PEPG) Stock Forecast & Price Target

PepGen Inc (PEPG) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 60%
Buy 20%
Hold 0%
Sell 20%
Strong Sell 0%

Bulls say

PepGen Inc. is positioned favorably in the biotechnology sector due to its Enhanced Delivery Oligonucleotide platform, which demonstrates a significant capacity for improving the delivery and efficacy of oligonucleotide therapeutics across various tissues. Notably, the company has reported a 53.7% splicing correction in preclinical studies for its product PGN-EDO53, which surpasses competitors' results and suggests a promising future for muscle performance improvements with repeat dosing in upcoming trials. With shares currently trading at approximately $4, the potential for substantial upside exists contingent on favorable outcomes from multi-dose data, aligning with the broader market sentiment reflected in similar companies’ valuations.

Bears say

PepGen Inc. is facing a negative outlook due to a recent adjustment in its target price, which reflects a $1 decrease to $8 per share, indicative of broader concerns regarding the company's market performance despite promising data from its drug pipeline. The company’s market valuation appears increasingly anomalous, particularly when compared to competitors like Dyne, which have demonstrated regulatory momentum and a more favorable position. Additionally, potential failures in commercial execution or challenges in accessing capital markets could lead to delays or termination of its development campaigns, further jeopardizing its financial stability and growth prospects.

PepGen Inc (PEPG) has been analyzed by 5 analysts, with a consensus rating of Buy. 60% of analysts recommend a Strong Buy, 20% recommend Buy, 0% suggest Holding, 20% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PepGen Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PepGen Inc (PEPG) Forecast

Analysts have given PepGen Inc (PEPG) a Buy based on their latest research and market trends.

According to 5 analysts, PepGen Inc (PEPG) has a Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $9.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $9.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PepGen Inc (PEPG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.